Metal Oxide Nanoparticles: Evidence of Adverse Effects on the Male Reproductive System
Overview
Chemistry
Molecular Biology
Affiliations
Metal oxide nanoparticles (MONPs) are inorganic materials that have become a valuable tool for many industrial sectors, especially in healthcare, due to their versatility, unique intrinsic properties, and relatively inexpensive production cost. As a consequence of their wide applications, human exposure to MONPs has increased dramatically. More recently, their use has become somehow controversial. On one hand, MONPs can interact with cellular macromolecules, which makes them useful platforms for diagnostic and therapeutic interventions. On the other hand, research suggests that these MONPs can cross the blood-testis barrier and accumulate in the testis. Although it has been demonstrated that some MONPs have protective effects on male germ cells, contradictory reports suggest that these nanoparticles compromise male fertility by interfering with spermatogenesis. In fact, in vitro and in vivo studies indicate that exposure to MONPs could induce the overproduction of reactive oxygen species, resulting in oxidative stress, which is the main suggested molecular mechanism that leads to germ cells' toxicity. The latter results in subsequent damage to proteins, cell membranes, and DNA, which ultimately may lead to the impairment of the male reproductive system. The present manuscript overviews the therapeutic potential of MONPs and their biomedical applications, followed by a critical view of their potential risks in mammalian male fertility, as suggested by recent scientific literature.
Advances in nano-delivery of phytochemicals for glioblastoma treatment.
Ambele M, Maebele L, Mulaudzi T, Kungoane T, Damane B Discov Nano. 2024; 19(1):216.
PMID: 39718730 PMC: 11668727. DOI: 10.1186/s11671-024-04172-9.
Antimicrobial Activity of -Mediated Gold Nanoparticles against : A Metabolomic and Docking Study.
Azmy L, Al-Olayan E, Abdelhamid M, Zayed A, Gheda S, Youssif K Int J Mol Sci. 2024; 25(18).
PMID: 39337576 PMC: 11432420. DOI: 10.3390/ijms251810090.
Abady M, Jeong J, Kwon H, Assiri A, Cho J, Saadeldin I Front Pharmacol. 2024; 15:1412188.
PMID: 38948466 PMC: 11211546. DOI: 10.3389/fphar.2024.1412188.
Behairy A, Hashem M, Abo-El-Sooud K, El-Metwally A, Soliman A, Mouneir S Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):9859-9875.
PMID: 38935127 PMC: 11582332. DOI: 10.1007/s00210-024-03228-y.
Nanoparticles incorporated hydrogels for delivery of antimicrobial agents: developments and trends.
Ahmad N, Bukhari S, Hussain M, Ejaz H, Munir M, Amjad M RSC Adv. 2024; 14(19):13535-13564.
PMID: 38665493 PMC: 11043667. DOI: 10.1039/d4ra00631c.